Skip to main content

and
  1. Article

    Open Access

    Correction: Epigenetic targeting of neuropilin-1 prevents bypass signaling in drug-resistant breast cancer

    Ammara Abdullah, Saeed Salehin Akhand, Juan Sebastian Paez Paez, Wells Brown in Oncogene (2023)

  2. Article

    Open Access

    Epigenetic targeting of neuropilin-1 prevents bypass signaling in drug-resistant breast cancer

    Human epidermal growth factor receptor 2 (HER2)-amplified breast cancers are treated using targeted antibodies and kinase inhibitors, but resistance to these therapies leads to systemic tumor recurrence of metast...

    Ammara Abdullah, Saeed Salehin Akhand, Juan Sebastian Paez Paez, Wells Brown in Oncogene (2021)

  3. Article

    Open Access

    Biased signaling downstream of epidermal growth factor receptor regulates proliferative versus apoptotic response to ligand

    Inhibition of epidermal growth factor receptor (EGFR) signaling by small molecule kinase inhibitors and monoclonal antibodies has proven effective in the treatment of multiple cancers. In contrast, metastatic ...

    Remah Ali, Wells Brown, Stephen Connor Purdy, V. Jo Davisson in Cell Death & Disease (2018)